Zhao, Shao-Jun <br/><br/>
A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.  [electronic resource] 

 -  International journal of nanomedicine  2017 
 - 2143-2160 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1178-2013 
<br/><br/><label>Standard No.: </label>10.2147/IJN.S130566  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--metabolism<br/>Cell Proliferation--drug effects<br/>Chitosan--chemistry<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug Liberation<br/>Exenatide<br/>Fasting--blood<br/>Glucose--metabolism<br/>Half-Life<br/>Hydrogen Peroxide--toxicity<br/>Insulin--genetics<br/>Insulin Resistance<br/>Male<br/>Mice<br/>Nanoparticles--chemistry<br/>Peptides--pharmacology<br/>RNA, Messenger--genetics<br/>Reactive Oxygen Species--metabolism<br/>Receptor, Insulin--metabolism<br/>Receptors, Vasoactive Intestinal Peptide, Type II--agonists<br/>Selenium--chemistry<br/>Venoms--therapeutic use